New EMD Serono Specialty Digest finds 'site of care' management a top payer priority
Do you know your J codes?
HCPC announces its Compliance Package of the Year
AstraZeneca's Seroquel XR sample kit takes top honors
Rep access to physicians continues its downward slide
If the count of working sales reps is rising, who will those reps be able to visit?
OptumRx-Catamaran merger brings further consolidation to US pharma market
$12.8-billion acquisition will bring 1 billion precriptions/year under one PBM's management
H. D. Smith reorganizes, expands upper management
Creation of a holding company streamlines future acquisitions; focus is on specialty drug services
'Dot-pharmacy' domain name is open for business at NABP
National association wins oversight for the valuable top-level domain (TLD), begins approving online pharmacies' use of it
Veeva Systems enlarges its stake in customer master data management (MDM)
Veeva OpenKey database service will provide a standardized quality level for global healthcare-provider reference data
Marken opens a Shanghai branch office for clinical logistics
Office will serve Shanghai and Suzhou life sciences clients
DSCSA compliance is forging ahead, says RxTrace survey
But a majority of dispensers (pharmacies) are not yet preparing for their July 1 deadline
Magellan Rx Management's annual report on medical pharmacy trend: up less than 10% in 2013
Top 25 medical-benefit drugs showed an 8% increase over prior year
Battle line sharpens with latest Express Scripts Drug Trend Report
Besides specialty pharmaceutical pricing, the cost of compounded drugs is highlighted
Reltio targets pharma sales and marketing with 'data as a service'
Company wins $10 million in venture capital as it lines up key life sciences service providers
Telemedicine's value is clear, but future growth needs clarity around standards and practices
Literature survey from Altarum Institute finds a growing body of evidence of value
Intelligent Hospital Systems buys AmerisourceBergen unit, shaking up pharmacy-automation field
IHS, hereafter to be known as ARxIUM, will expand its injectable-compounding business to include oral solids
Politics and drugs
Medical marijuana and biosimilars are two topics where 'the will of the people' push decisions
A conversation with W. Scott Evangelista, Quintiles
Manufacturers: Get ready for global trade account management
Partnering to diversify yields rapid growth
A family-owned pharmaceutical manufacturer plots a 21st-century growth plan
Purdue Pharma exec and Cardinal Health win HDMA distribution awards
AmerisourceBergen-Walgreens Alliance Boots, and H. D. Smith-Legisym are runners-up
Campbell Alliance updates, expands its commercial launch consulting services
More executional capabilities derive from affiliation with parent, inVentiv Health
HealthPrize touts its success with 'gamification' in adherence programs
Company uses online media to promote fill rates by more than 50%
Exostar grows its network of collaborative tools in life sciences
Identity Hub expedites access to regulated content in prescribing and other commercial applications
Symphony Health Solutions builds a 5-million-patient, longitudinal cardiovascular registry
Collaboration with American College of Cardiology could result in new health-outcomes results
Rite Aid to buy EnvisionRx, continuing a reshaping of US drug distribution
$2-billion acquisition brings a $5-billion/yr PBM to Rite Aid's 4,600 retail stores
Independent physicians and their clinics remain a dominant channel for specialty distribution, says HDMA
Association's annual specialty-distribution study focuses trend in oncology, chronic diseases
Preventing and Managing Drug Shortages--PDA Technical Report 68
The Parenteral Drug Association offers risk management guidance*
'Capacity crunch' is the theme of HPCLC meeting
2015 spring meeting focuses on meeting transportation bottlenecks
Alliance Life Sciences partners with Revitas to better manage pharma revenue practices
1.5-10% improvement in 'revenue capture' is possible
Next agg-spend deadline looms with little buzz from industry
Reporting by pharma companies on spending on physicians is becoming a non-event
The biosimilars payoff in the US might be small and fleeting
Analysis from Prime Therapeutics points to severe cost hurdles for biosimilars developed and marketed in the US
